Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke

Christopher T. Simons, Jason M. Cuellar, Justin A. Moore, Kent E Pinkerton, Dale Uyeminami, Mirela Iodi Carstens, Earl Carstens

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Direct exposure of rats to tobacco smoke induces antinociception. We presently investigated if this antinociception is mediated via nicotinic and/or μ-opioid receptors. Adult male rats were surgically implanted with Alzet osmotic minipumps that delivered either saline (control), the nicotinic antagonist mecamylamine, or the opiate antagonist naltrexone (3 mg/kg/day i.v. for 21 days). Nocifensive responses were assessed on alternate days using tail-flick reflex latency (TFL) over a 3-week period. During the second week, the rats were exposed to concentrated cigarette smoke in an environmental chamber for 6 h/day for 5 consecutive days; a control group was similarly exposed to filtered cigarette smoke. Rats receiving mecamylamine and naltrexone exhibited a significant weight loss after the first day of infusion. All treatment groups additionally exhibited significant weight loss during exposure to unfiltered or filtered smoke. The saline group exhibited significant antinociception on the first day of smoke exposure with rapid development of tolerance. The mecamylamine and naltrexone groups did not exhibit significant antinociception. Controls exposed to filtered smoke (with ∼50% lower nicotine concentration) also exhibited significant analgesia on the first exposure day with rapid development of tolerance. Exposure to high levels of cigarette smoke, or to filtered smoke with a lower nicotine concentration in the vapor phase, induces antinociception with rapid development of tolerance. The antinociceptive effect appears to be mediated via nicotinic and μ-opioid receptors.

Original languageEnglish (US)
Pages (from-to)71-76
Number of pages6
JournalNeuroscience Letters
Volume389
Issue number2
DOIs
StatePublished - Dec 2 2005

Fingerprint

Nicotinic Receptors
Smoke
Tobacco Products
Mecamylamine
Naltrexone
Opioid Receptors
Nicotine
Opiate Alkaloids
Weight Loss
Nicotinic Antagonists
Analgesia
Tobacco
Reflex
Tail
Control Groups

Keywords

  • Analgesia
  • Antinociception
  • Cigarette smoke
  • Nicotine
  • Opiates

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Simons, C. T., Cuellar, J. M., Moore, J. A., Pinkerton, K. E., Uyeminami, D., Carstens, M. I., & Carstens, E. (2005). Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. Neuroscience Letters, 389(2), 71-76. https://doi.org/10.1016/j.neulet.2005.07.025

Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. / Simons, Christopher T.; Cuellar, Jason M.; Moore, Justin A.; Pinkerton, Kent E; Uyeminami, Dale; Carstens, Mirela Iodi; Carstens, Earl.

In: Neuroscience Letters, Vol. 389, No. 2, 02.12.2005, p. 71-76.

Research output: Contribution to journalArticle

Simons, CT, Cuellar, JM, Moore, JA, Pinkerton, KE, Uyeminami, D, Carstens, MI & Carstens, E 2005, 'Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke', Neuroscience Letters, vol. 389, no. 2, pp. 71-76. https://doi.org/10.1016/j.neulet.2005.07.025
Simons, Christopher T. ; Cuellar, Jason M. ; Moore, Justin A. ; Pinkerton, Kent E ; Uyeminami, Dale ; Carstens, Mirela Iodi ; Carstens, Earl. / Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. In: Neuroscience Letters. 2005 ; Vol. 389, No. 2. pp. 71-76.
@article{9a4cf1de055a404c910485a6f29725e3,
title = "Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke",
abstract = "Direct exposure of rats to tobacco smoke induces antinociception. We presently investigated if this antinociception is mediated via nicotinic and/or μ-opioid receptors. Adult male rats were surgically implanted with Alzet osmotic minipumps that delivered either saline (control), the nicotinic antagonist mecamylamine, or the opiate antagonist naltrexone (3 mg/kg/day i.v. for 21 days). Nocifensive responses were assessed on alternate days using tail-flick reflex latency (TFL) over a 3-week period. During the second week, the rats were exposed to concentrated cigarette smoke in an environmental chamber for 6 h/day for 5 consecutive days; a control group was similarly exposed to filtered cigarette smoke. Rats receiving mecamylamine and naltrexone exhibited a significant weight loss after the first day of infusion. All treatment groups additionally exhibited significant weight loss during exposure to unfiltered or filtered smoke. The saline group exhibited significant antinociception on the first day of smoke exposure with rapid development of tolerance. The mecamylamine and naltrexone groups did not exhibit significant antinociception. Controls exposed to filtered smoke (with ∼50{\%} lower nicotine concentration) also exhibited significant analgesia on the first exposure day with rapid development of tolerance. Exposure to high levels of cigarette smoke, or to filtered smoke with a lower nicotine concentration in the vapor phase, induces antinociception with rapid development of tolerance. The antinociceptive effect appears to be mediated via nicotinic and μ-opioid receptors.",
keywords = "Analgesia, Antinociception, Cigarette smoke, Nicotine, Opiates",
author = "Simons, {Christopher T.} and Cuellar, {Jason M.} and Moore, {Justin A.} and Pinkerton, {Kent E} and Dale Uyeminami and Carstens, {Mirela Iodi} and Earl Carstens",
year = "2005",
month = "12",
day = "2",
doi = "10.1016/j.neulet.2005.07.025",
language = "English (US)",
volume = "389",
pages = "71--76",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke

AU - Simons, Christopher T.

AU - Cuellar, Jason M.

AU - Moore, Justin A.

AU - Pinkerton, Kent E

AU - Uyeminami, Dale

AU - Carstens, Mirela Iodi

AU - Carstens, Earl

PY - 2005/12/2

Y1 - 2005/12/2

N2 - Direct exposure of rats to tobacco smoke induces antinociception. We presently investigated if this antinociception is mediated via nicotinic and/or μ-opioid receptors. Adult male rats were surgically implanted with Alzet osmotic minipumps that delivered either saline (control), the nicotinic antagonist mecamylamine, or the opiate antagonist naltrexone (3 mg/kg/day i.v. for 21 days). Nocifensive responses were assessed on alternate days using tail-flick reflex latency (TFL) over a 3-week period. During the second week, the rats were exposed to concentrated cigarette smoke in an environmental chamber for 6 h/day for 5 consecutive days; a control group was similarly exposed to filtered cigarette smoke. Rats receiving mecamylamine and naltrexone exhibited a significant weight loss after the first day of infusion. All treatment groups additionally exhibited significant weight loss during exposure to unfiltered or filtered smoke. The saline group exhibited significant antinociception on the first day of smoke exposure with rapid development of tolerance. The mecamylamine and naltrexone groups did not exhibit significant antinociception. Controls exposed to filtered smoke (with ∼50% lower nicotine concentration) also exhibited significant analgesia on the first exposure day with rapid development of tolerance. Exposure to high levels of cigarette smoke, or to filtered smoke with a lower nicotine concentration in the vapor phase, induces antinociception with rapid development of tolerance. The antinociceptive effect appears to be mediated via nicotinic and μ-opioid receptors.

AB - Direct exposure of rats to tobacco smoke induces antinociception. We presently investigated if this antinociception is mediated via nicotinic and/or μ-opioid receptors. Adult male rats were surgically implanted with Alzet osmotic minipumps that delivered either saline (control), the nicotinic antagonist mecamylamine, or the opiate antagonist naltrexone (3 mg/kg/day i.v. for 21 days). Nocifensive responses were assessed on alternate days using tail-flick reflex latency (TFL) over a 3-week period. During the second week, the rats were exposed to concentrated cigarette smoke in an environmental chamber for 6 h/day for 5 consecutive days; a control group was similarly exposed to filtered cigarette smoke. Rats receiving mecamylamine and naltrexone exhibited a significant weight loss after the first day of infusion. All treatment groups additionally exhibited significant weight loss during exposure to unfiltered or filtered smoke. The saline group exhibited significant antinociception on the first day of smoke exposure with rapid development of tolerance. The mecamylamine and naltrexone groups did not exhibit significant antinociception. Controls exposed to filtered smoke (with ∼50% lower nicotine concentration) also exhibited significant analgesia on the first exposure day with rapid development of tolerance. Exposure to high levels of cigarette smoke, or to filtered smoke with a lower nicotine concentration in the vapor phase, induces antinociception with rapid development of tolerance. The antinociceptive effect appears to be mediated via nicotinic and μ-opioid receptors.

KW - Analgesia

KW - Antinociception

KW - Cigarette smoke

KW - Nicotine

KW - Opiates

UR - http://www.scopus.com/inward/record.url?scp=24144452430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144452430&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2005.07.025

DO - 10.1016/j.neulet.2005.07.025

M3 - Article

C2 - 16095820

AN - SCOPUS:24144452430

VL - 389

SP - 71

EP - 76

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -